# The Medicines (Fees Relating to Medicinal Products for Animal Use) Regulations 1994, Paragraph 1


Where the manufacture, assembly, sale or supply of medicinal products of a particular class or description will be, or is likely to be, interrupted for a period, and in consequence thereof the health of animals will be, or is likely to be, put at risk, the licensing authority may decide that any fees otherwise payable under these Regulations—
(a) in connection with an application for the grant (variation or renewal) of a product licence relating to a medicinal product falling within that class or description; or
(b) in respect of any inspection made during the currency of such a licence
shall be waived during that particular period or, if the period will, or is likely to, exceed 3 months, during the first 3 months of that period.

---
Source: https://www.legislation.gov.uk/uksi/1994/1554/schedule/6/paragraph/1 (the official version)
Page: https://openlegislation.uk/medicines-fees-relating-to-medicinal-products-for-animal-use-regulations-1994/schedule-6/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

